FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Pfizer TORISEL Kit Recall

TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a c…

Pfizer Inc. · New York, NY

Risk level
Class III
Reported by FDA
Apr 3, 2013
Recall ID
D-219-2013
Check your lot numberHow we source this data

Summary

Pfizer recalled TORISEL Kit starting Nov 26, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-219-2013 on Apr 3, 2013. Reason: Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.

Product description

TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01

Lot numbers, UPCs & expiration codes

Lots P00025A; P00027B

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-219-2013
Classification
Class III
Status
Terminated
Recall initiated
Nov 26, 2012
FDA report date
Apr 3, 2013
Quantity
10920 kits
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-219-2013, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
64690
Address
235 East 42nd Street
Code information
Lots P00025A; P00027B
Postal code
10017-5703
Report date
Apr 3, 2013
Product type
Drugs
Recall number
D-219-2013
Classification
Class III
Recalling firm
Pfizer Inc.
Product quantity
10920 kits
Termination date
Mar 31, 2015
Reason for recall
Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.
Voluntary / mandated
Voluntary: Firm initiated
Product description
TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01
Distribution pattern
Nationwide
Recall initiation date
Nov 26, 2012
Initial firm notification
Letter
Center classification date
Mar 26, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-219-2013, published Apr 3, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls